期刊文献+

某种人类免疫缺陷病毒Ⅰ型核酸定量检测试剂盒的性能评估 被引量:9

Evaluation of a new quantitative detection kit for human immunodeficiency virus type1 RNA
原文传递
导出
摘要 目的对某种人类免疫缺陷病毒Ⅰ型(HIV-1)核酸定量检测试剂盒(PCR-荧光探针法)的临床应用性能进行评估。方法收集不同HIV感染状态人群的血液样品共计109份,分别使用HIV-1被评估试剂与参比试剂的核酸定量检测试剂盒进行平行对比试验。统计学处理使用Kappa值、R2和Bland-Altman模型。结果被评估试剂检测结果相对于参比试剂,检测结果的总符合率为97.25%(95%CI:92.17%~99.43%),Kappa值为0.92(P<0.001),一致性强度为最强。109例样本中,均在被评估试剂与参比试剂定量检测范围内的样本为84例,两种试剂盒检测结果的回归分析表现出较强的相关性(R2=0.853 6)。使用Bland-Altman模型比较两种试剂检测结果的差异均值,结果显示对于未进行抗病毒治疗的HIV感染者样本两种试剂检测结果具有较好的一致性。结论被评估试剂和参比试剂对同一份血浆样本检测结果具有较好的定性符合程度和较强的相关性,对HIV感染者样本两试剂检测结果有较强的定量一致性。 Objective To evaluate the variation and stability of a new quantitative detection kit for human immu- nodeficiency virus type 1 ( HIV-1 ) nucleic acid. Methods A total of 109 plasma samples were detected by both the evalu- ated kit and the COBAS Taqman analyzing system. The results of the two methods were compared by kappa number, R square and Bland-Airman plot. Results The consistency of the evaluated kit with the reference kit was 97.25% (95% CI: 92. 17% -99.43% ) ,and Kappa value was 0.92 (P 〈0. 001 ). Out of 109 paired plasma tested, 84 samples were quantifi- able by both kits. There was a strong overall correlation of the test results between the two methods (R2 =0. 853 6). Com- parison of the mean test results with differences of the two methods using the Bland Altman plot showed that there were good consistency between the test results of the evaluated kit and the reference kit when detecting the samples of HIV infectors without HARRT. Conclusions High qualitative consistency and strong correlation between the evaluated kit and the refer- ence kit were found, as well as strong quantitative consistency of the test results of samples from the HIV infectors.
出处 《中华疾病控制杂志》 CAS 北大核心 2013年第7期605-608,共4页 Chinese Journal of Disease Control & Prevention
基金 北京市科委科技计划项目(D09050704090905) 国家科技重大专项(2013ZX10001001-001-007)
关键词 HIV-1 聚合酶连反应 评价研究 HIV-1 Polymerase chain reaction Evaluation studies
  • 相关文献

参考文献5

二级参考文献17

  • 1何卫华,周沛林,何华仙,张杨,黄希平,吴晓云,张绍兰.艾滋病病毒耐药性及其影响因素的研究[J].疾病控制杂志,2006,10(3):259-261. 被引量:8
  • 2张春迎,陈军,郑煜煌,雷建华,周华英,张永红,何艳,罗开忠,蒋永芳,欧秋英,黄竹林.艾滋病患者高效抗逆转录病毒治疗两年的效果和副作用[J].中华内科杂志,2006,45(6):494-496. 被引量:33
  • 3中国疾病预防控制中心.国家免费艾滋病抗病毒药物治疗手册[M].北京:人民卫生出版社,2008:86-88.
  • 4WHO. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach (2006 revision) [DB/OL]. (2006-08-07)[2009-08-20]. http://www. who. int/hiv/pub/guidelines/artadultguidelines, pdf.
  • 5WHO. Important: addendum to 2006 WHO guidelines on antiretroviral therapy for HIV infection in adults and adolescents (2006) [ DB/OL ]. http://www, who. int/hiv/art/ARTadult-saddendum, pdf.
  • 6Ghani AC, Ferguson NM, Fraser C, et al. Viral replication under combination antiretroviral therapy: a comparison of four different regimens [J]. J Acquit Immune Defic Syndr, 2002,30 (2) : 167-176.
  • 7UK Collaborative Group on Monitoring the Transmission of HIV Drug Resistance. Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom [J]. BMJ, 2001, 322 : 1087-1088.
  • 8Little SJ. Transmission and prevalence of HIV resistance among treatment-naive subjects [J]. Antivir Ther, 2000,5( 1 ):33-40.
  • 9Li TS, Tubiana R, Katlama C, et al. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active an- ti'retrovlral therapy in advanced HIV-1 disease [J ]. Lancet, 1998,351(9117) : 1682-1686.
  • 10Polis MA, Sidorov IA, Yoder C, et al. Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacy [J ]. Lancet, 2001,358(9295) : 1760-1765.

共引文献23

同被引文献60

引证文献9

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部